We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warning Letters Advocate Expanded Failure Investigations
FDA Warning Letters Advocate Expanded Failure Investigations
February 5, 2010
Two recent FDA warning letters signal that drugmakers should investigate whether potential good manufacturing practice violations found in one batch may affect other batches or products.